Bing Guo

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation

Lingling Liu, Yuanyuan Wang, Rui Yan et al. · Life Sciences · 2019 · 89 citations

Medicine, Molecular Medicine, Nephrology +14

Transcriptome analysis of cattle muscle identifies potential markers for skeletal muscle growth rate and major cell types

Bing Guo, P. L. Greenwood, L. M. Cafe et al. · BMC Genomics · 2015 · 66 citations · Full text

Life Sciences, Animal Sciences, Developmental Biology +16

Oxymatrine Inhibits Renal Tubular EMT Induced by High Glucose via Upregulation of SnoN and Inhibition of TGF-β1/Smad Signaling Pathway

Lirong Liu, Yuanyuan Wang, Rui Yan et al. · PLoS ONE · 2016 · 54 citations · Full text

Life Sciences, Biochemistry, Cell Biology +15